MHC-peptide complex binding ligands
OwnerHenricus Renerus Jacobus Mattheus Hoogenboom, Yoram Reiterinventors
Life of this patent
Estimating the term…
Abstract
Disclosed are protein ligands comprising an immunoglobulin heavy chain variable (VH) domain and an immunoglobulin light chain variable (VL) domain, wherein the proteins bind a complex comprising an MHC and a peptide, do not substantially bind the MHC in the absence of the bound peptide, and do not substantially bind the peptide in the absence of the MHC, and the peptide is a peptide fragment of gp100, MUC1, TAX, or hTERT. Also disclosed are methods of using and identifying such ligands.
Claims49
A protein comprising an immunoglobulin heavy chain variable (VH) domain and an immunoglobulin light chain variable (VL) domain, wherein the protein binds a complex comprising an MHC and a peptide, does not substantially bind the MHC in the absence of the bound peptide, and does not substantially bind the peptide in the absence of the MHC, and the peptide is a peptide fragment of gp100, MUC1, TAX, or hTERT.
A cytotoxic T cell that comprises one or more nucleic acids for expressing an immunoglobulin that binds a complex comprising an MHC and a peptide, does not substantially bind the MHC in the absence of the bound peptide, and does not substantially bind the peptide in the absence of the MHC.
An isolated nucleic acid comprising a first segment that encodes an immunoglobulin variable domain, wherein a protein that comprises the immunoglobulin variable domain and a second immunoglobulin variable domain binds to an MHC-peptide complex, does not substantially bind the MHC in the absence of the bound peptide, and does not substantially bind the peptide in the absence of the MHC, and the peptide is a peptide fragment of gp100, MUC1, TAX, or hTERT.
A host cell comprising heterologous nucleic acid sequences that encode a protein comprising an immunoglobulin heavy chain variable domain and an immunoglobulin light chain variable domain, wherein the protein binds to an MHC-peptide complex if the peptide is present in the complex, and the peptide is a peptide fragment of gp100, MUC1, TAX, or hTERT.
A transgenic animal whose genome includes heterologous nucleic acid sequences that encode a protein comprising an immunoglobulin heavy chain variable domain and an immunoglobulin light chain variable domain, wherein the protein binds to an MHC-peptide complex if the peptide is present in the complex, and the peptide is a peptide fragment of gp100, MUC1, TAX, or hTERT.
A method comprising:
- providing a protein library that comprises proteins, each protein comprising a immunoglobulin variable domain from a subject with a preselected MHC allele;
- optionally selecting an MHC complex known to comprise the same allele as the preselected allele;
- contacting the library to an MHC-peptide complex, wherein the MHC component of the complex is the same allele as the given preselected MHC allele;
- and
- isolating a member of the library that specifically binds the MHC-peptide complex.
A method comprising:
- contacting members of a protein library to a single-chain MHC-peptide complex;
- and;
- identifying one or more members that bind to the single-chain MHC-peptide complex, do not substantially bind the MHC in the absence of the peptide, and do not substantially bind the peptide in the absence of the MHC.
A method comprising:
- contacting a protein library to a first mixture of MHC-peptide complexes;
- isolating a plurality of members of the library, wherein each isolated member of the plurality displays an antigen binding domain that binds to an MHC-peptide complex and the epitope recognized by the antigen binding domain comprises a moiety of the MHC and a moiety of the peptide;
- and
- identifying members of the plurality that do not substantially bind to a second mixture of MHC-peptide complexes.
A method comprising:
- providing a first nucleic acid segment encoding a heavy chain variable region and a second nucleic acid segment encoding a light chain variable region, wherein the heavy chain variable region and the light chain variable region form an antigen binding protein that binds an MHC-target peptide complex if the target peptide is present;
- introducing said first and second nucleic acid segments into a cytotoxic cell;
- and
- maintaining the cytotoxic cell under conditions that allow expression and assembly of said antigen-binding protein.
A method comprising:
- providing a first nucleic acid segment encoding a heavy chain variable region and a second nucleic acid segment encoding a light chain variable region, wherein the heavy chain variable region and the light chain variable region form an antigen binding protein that binds an MHC-target peptide complex if the target peptide is present and the target peptide is a peptide fragment of gp100, MUC1, TAX, or hTERT;
- introducing said first and second nucleic acid segments into a host cell;
- and
- maintaining the host cell under conditions that allow expression and assembly of said antigen-binding protein.
Dependencies are inferred from the claim text.